Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$582K Sell
47,600
-100,800
-68% -$1.78M 0.01% 1534
2017
Q2
$2.71M Buy
148,400
+137,200
+1,225% +$2.53M 0.05% 495
2017
Q1
$237K Buy
+11,200
New +$219K 0.01% 1801
2016
Q3
Sell
-60,000
Closed -$1.19M 3157
2016
Q2
$1.19M Buy
60,000
+54,400
+971% +$926K 0.02% 1008
2016
Q1
$95K Buy
+5,600
New +$93.5K ﹤0.01% 2590
2015
Q4
Sell
-82,000
Closed -$1.76M 3711
2015
Q3
$1.76M Buy
82,000
+81,200
+10,150% +$1.81M 0.02% 1176
2015
Q2
$16K Buy
+800
New +$14.1K ﹤0.01% 3498

Other funds holding DXCM

Spot Trading's DXCM Position: Q3 2017 in Review

Spot Trading increased its DexCom (DXCM) stake by 72% in Q3 2017, buying an estimated $129K and bringing the position to 17,444 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Spot Trading first reported a position in DXCM in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.17M in Q2 2016. 275 funds tracked by Wall St. Rank hold DXCM as of Q3 2017.

  • Spot Trading held 17,444 shares of DexCom worth $213K as of Q3 2017.
  • Spot Trading bought 7,316 DexCom shares in Q3 2017, an estimated $129K.
  • DexCom made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2192 holding.
  • Spot Trading first reported a position in DexCom in Q2 2015 and has held it in 7 quarters since.
  • Spot Trading's DexCom position peaked at $1.17M in Q2 2016.
  • 275 funds tracked by Wall St. Rank held DexCom as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.